Cast OFF Trial: One Versus Four-five Weeks of Plaster Cast Immobilization
Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Aug 2, 2017
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 75 years
- • Isolated acute distal radius fracture
- • Closed reduction is not performed
- • Non-operative treatment with cast immobilisation
- • Understanding of Dutch language
- Exclusion Criteria:
- • Under the age of 18 or older than 75 years
- • Multiple injured patient
- • Reduction is indicated/performed
- • Operative treatment
- • Not understanding of Dutch language
About Radboud University Medical Center
Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ede, , Netherlands
Arnhem, , Netherlands
Nijmegen, , Netherlands
Patients applied
Trial Officials
JP Frolke, Dr.
Principal Investigator
Radboud University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials